2005•Zhongguo yaofangRequires access

Study on the Relative Bioavailability of Yifuxian'an Capsules in Human Body

Guo Yan-rong

Open publisher page 0 citations

Abstract

OBJECTIVE:To study the relative bioavailability of yifuxian'an capsules.METHODS:Concentrations of ri-fampicin,isoniazid and pyrazinamide in plasma were determined on12volunteers respectively after a single oral dose of yifux-ian'an capsules(tested preparations)and rifater(reference preparation)by RP-HPLC method;the pharmacokinetics parame-ters were processed by3p97process.RESULTS:The AUC 0~t of the tested preparation and reference substance of rifampicin were(70.69±36.32)and(70.77±32.26)(μg·h)/ml respectively,t max of which were(1.82±0.28)and(1.79±0.25)h re-spectively,C max of which were(12.83±4.98)μg/ml and(12.84±3.95)μg/ml respectively;The AUC 0~t of which were(14.30±8.25)and(13.76±6.16)(μg·h)/ml respectively,t max of which were(1.54±0.36)and(1.58±0.38)h respectively,C max of which were(5.42±2.52)and(5.46±2.46)μg/ml respectively;The AUC 0~t of which of pyrazinamide were(243.56±128.98)and(238.07±117.63)(μg·h)/ml respectively,t max of which were(1.58±0.64)and(1.69±0.55)h respectively,C max of which were(29.45±12.45)and(27.46±11.02)μg/ml respectively.The relative bioequivalence of rifampicin,isoniazid and pyrazi-namide of the tested preparation were(99.88±12.92)%,(103.84±24.10)%and(102.57±12.31)%respectively.CONCLU-SION:Bioavailability of the2preparations are bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To study the relative bioavailability of yifuxian'an capsules.METHODS:Concentrations of ri-fampicin,isoniazid and pyrazinamide in plasma were determined on12volunteers respectively after a single oral dose of yifux-ian'an capsules(tested preparations)and rifater(reference preparation)by RP-HPLC method;the pharmacokinetics parame-ters were processed by3p97process.RESULTS:The AUC 0~t of the tested preparation and reference substance of rifampicin were(70.69±36.32)and(70.77±32.26)(μg·h)/ml respectively,t max of which were(1.82±0.28)and(1.79±0.25)h re-spectively,C max of which were(12.83±4.98)μg/ml and(12.84±3.95)μg/ml respectively;The AUC 0~t of which were(14.30±8.25)and(13.76±6.16)(μg·h)/ml respectively,t max of which were(1.54±0.36)and(1.58±0.38)h respectively,C max of which were(5.42±2.52)and(5.46±2.46)μg/ml respectively;The AUC 0~t of which of pyrazinamide were(243.56±128.98)and(238.07±117.63)(μg·h)/ml respectively,t max of which were(1.58±0.64)and(1.69±0.55)h respectively,C max of which were(29.45±12.45)and(27.46±11.02)μg/ml respectively.The relative bioequivalence of rifampicin,isoniazid and pyrazi-namide of the tested preparation were(99.88±12.92)%,(103.84±24.10)%and(102.57±12.31)%respectively.CONCLU-SION:Bioavailability of the2preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study the relative bioavailability of yifuxian'an capsules.METHODS:Concentrations of ri-fampicin,isoniazid and pyrazinamide in plasma were determined on12volunteers respectively after a single oral dose of yifux-ian'an capsules(tested preparations)and rifater(reference preparation)by RP-HPLC method;the pharmacokinetics parame-ters were processed by3p97process.RESULTS:The AUC 0~t of the tested preparation and reference substance of rifampicin were(70.69±36.32)and(70.77±32.26)(μg·h)/ml respectively,t max of which were(1.82±0.28)and(1.79±0.25)h re-spectively,C max of which were(12.83±4.98)μg/ml and(12.84±3.95)μg/ml respectively;The AUC 0~t of which were(14.30±8.25)and(13.76±6.16)(μg·h)/ml respectively,t max of which were(1.54±0.36)and(1.58±0.38)h respectively,C max of which were(5.42±2.52)and(5.46±2.46)μg/ml respectively;The AUC 0~t of which of pyrazinamide were(243.56±128.98)and(238.07±117.63)(μg·h)/ml respectively,t max of which were(1.58±0.64)and(1.69±0.55)h respectively,C max of which were(29.45±12.45)and(27.46±11.02)μg/ml respectively.The relative bioequivalence of rifampicin,isoniazid and pyrazi-namide of the tested preparation were(99.88±12.92)%,(103.84±24.10)%and(102.57±12.31)%respectively.CONCLU-SION:Bioavailability of the2preparations are bioequivalent.

Key concepts: Bioavailability, Bioequivalence, Pyrazinamide, Rifampicin, Pharmacokinetics, Isoniazid, Chemistry, Chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the Relative Bioavailability of Yifuxian'an Capsules in Human Body — Research Paper | ScholarLens